N.J. school nurse ousted after going maskless at work to protest mask mandate's harm to children
Erin Pein said that she has "witnessed these kids being harmed physically, emotionally and developmentally because of these masks."
A suspended New Jersey school nurse is sounding the alarm about the deleterious effects of forcing children to wear face masks amid the COVID-19 pandemic.
During an interview on the John Solomon Reports podcast, Erin Pein said that she has "witnessed these kids being harmed physically, emotionally and developmentally because of these masks. And I put my job on the line to help and protect them. And it's time for every teacher who cares about kids, every doctor who took an oath and every nurse who's a patient advocate to stand up and make a stand and start protecting these kids."
Pein said that she raised her concerns with the nursing supervisor via email, but the supervisor indicated that the mask mandate would continue in force, and when she then requested to speak to the school superintendent, the nursing supervisor failed to respond to that request.
Pein said that she decided not to wear a mask while working, and she posted a video on a Facebook parent group featuring a nurse showing "how to safely use and reuse a face mask to prevent cross contamination."
But Pein, who had worked in the Stafford Township School District, said that she was suspended without pay. She said that she has been informed that the board of education voted not to renew her contract, which means she will be cut loose at the end of June. However, Pein said she learned there is a plan to reinstate her pay amid the suspension.
News, not Noise
- Effort to spread discredited Russia collusion theory welcomed by McCain Senate panel, memos show
- Draft report of Maricopa audit finds Biden won but flags as many as 44,000 votes as 'critical'
- White House tells agencies to begin preparing for potential government shutdown
- Ten questions the Arizona election audit could answer Friday
- DeSantis sidesteps Biden rationing, acquires new monoclonal antibodies from U.K. drug firm